Riskpilot← Back to searchSign inGet full accessSHC Nordic ApS
APSActiveCVR 40733280Kræen Bjergensvej 12Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20191 employees
Revenue 2024
DKK 1,2M
-55% vs 2023
EBITDA margin
2.4%
-93% vs 2023
Equity ratio
76.4%
Financial strength
Net profit 2024
DKK 31K
-91% vs 2023
| Revenue | DKK 1,2M | -55% |
| EBITDA | DKK 28K | -93% |
| Net profit | DKK 31K | -91% |
| Total assets | DKK 481K | -64% |
| Equity | DKK 367K | -48% |
| Employees | 1 | — |
Legal name
SHC Nordic ApS
CVR number
40733280
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
14. august 2019
Share capital
DKK 25.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden, af to bestyrelsesmedlemmer i forening eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive handel med medicinsk- og laboratorieudstyr samt anden dermed efter bestyrelsens skøn beslægtet virksomhed.
Address
Kræen Bjergensvej 12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1.486 | 3.228 | 3.309 | 2.592 | 1.164 |
| Staff expenses | -1.411 | -1.867 | -2.197 | -2.161 | -1.136 |
| EBITDA | 76 | 1.361 | 1.112 | 431 | 28 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | 76 | 1.361 | 1.112 | 431 | 28 |
| Net financials | -10 | -8 | -8 | 9 | 12 |
| Profit before tax | 65 | 1.353 | 1.104 | 440 | 40 |
| Tax | 18 | 298 | 244 | 97 | 9 |
| Net profit | 48 | 1.055 | 860 | 343 | 31 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 455 | 1.830 | 1.644 | 1.342 | 481 |
| Equity | 235 | 1.291 | 1.258 | 708 | 367 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 219 | 539 | 385 | 633 | 113 |
| Total debt | 219 | 539 | 385 | 633 | 113 |
EBITDA margin
2.4%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
76.4%
This company
38.2%
Market median
+100% vs market
20202024
Return on equity
8.4%
This company
18.4%
Market median
-54% vs market
20202024
Net profit margin
2.6%
This company
8.1%
Market median
-68% vs market
20202024
Asset turnover
2.42×
This company
1.12×
Market median
+116% vs market
20202024
Debt / equity
0.31×
This company
0.62×
Market median
+50% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-08-14 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Founder | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2019 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2024 | |
Fameco Group ApS | Company | 50.0% | 50.0% | 2021 |
FNUI Group ApS | Company | 50.0% | 50.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SHC Nordic ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Fameco Analytical Instruments S.à r.l. | Founder | 0 companies |
| Tim Gabriel Stjernberg | Board of Directors | 0 companies |
| Jarkko Juhani Rinne | Chairman | 0 companies |
| Thomas Andersen | Board of Directors | 0 companies |
| Anders Fage Jensen | Chairman | 0 companies |